The global photomedicine devices and technologies market is projected to grow from USD 4.50 billion in 2025 to around USD 11.44 billion by 2034, expanding at a CAGR of 10.91%. Growth is driven by rising demand for vision correction surgeries, increasing prevalence of skin diseases and cancer, and expanding applications in dermatology and oncology.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Photomedicine Devices and Technologies Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Photomedicine Devices and Technologies Market Revenue and Volume, By Product
8.1.1 Dermatology
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Wound healing
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Pain management
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Oncology
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Optical diagnostics
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Dental procedures
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Others
8.1.7.1. Market Revenue and Volume Forecast
9.1. Photomedicine Devices and Technologies Market Revenue and Volume, By Technology
9.1.1. Laser
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Construction & Building Services
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Polychromatic polarized light
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Full spectrum light
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Dichroic lamps
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Light-emitting diodes
9.1.6.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Product
10.1.2. Market Revenue and Volume Forecast, By Technology
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Product
10.1.3.2. Market Revenue and Volume Forecast, By Technology
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Product
10.1.4.2. Market Revenue and Volume Forecast, By Technology
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Product
10.2.2. Market Revenue and Volume Forecast, By Technology
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Product
10.2.3.2. Market Revenue and Volume Forecast, By Technology
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Product
10.2.4.2. Market Revenue and Volume Forecast, By Technology
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Product
10.2.5.2. Market Revenue and Volume Forecast, By Technology
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Product
10.2.6.2. Market Revenue and Volume Forecast, By Technology
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Product
10.3.2. Market Revenue and Volume Forecast, By Technology
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Product
10.3.3.2. Market Revenue and Volume Forecast, By Technology
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Product
10.3.4.2. Market Revenue and Volume Forecast, By Technology
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Product
10.3.5.2. Market Revenue and Volume Forecast, By Technology
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Product
10.3.6.2. Market Revenue and Volume Forecast, By Technology
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Product
10.4.2. Market Revenue and Volume Forecast, By Technology
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Product
10.4.3.2. Market Revenue and Volume Forecast, By Technology
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Product
10.4.4.2. Market Revenue and Volume Forecast, By Technology
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Product
10.4.5.2. Market Revenue and Volume Forecast, By Technology
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Product
10.4.6.2. Market Revenue and Volume Forecast, By Technology
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Product
10.5.2. Market Revenue and Volume Forecast, By Technology
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Product
10.5.3.2. Market Revenue and Volume Forecast, By Technology
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Product
10.5.4.2. Market Revenue and Volume Forecast, By Technology
11.1. Galderma
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Lumenis
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. THOR Photomedicine Ltd
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Alma Lasers Ltd
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. QBMI Photomedicine
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. AngioDynamics
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. IRIDEX Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Spectranetics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Syneron Medical Ltd
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Candela
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description